Articles
May 12, 2026
We Analyzed 6 Tremor Devices. Which One Is Actually Worth It in 2026?
A deep-dive into tirzepatide's weight loss evidence, dual GIP/GLP-1 mechanism, published dosing protocols, side effects, and how it compares to semaglutide.
May 12, 2026
BPC-157 Oral Bioavailability: Myth vs. Evidence
The claim that BPC-157 is orally bioavailable circulates widely in peptide forums. Here is what the actual literature supports and where the myth breaks down.
May 12, 2026
Selank for Anxiety: What the Research Protocols Show
A source-anchored review of Selank research protocols for anxiety — doses, routes, durations, reported outcomes, and open questions from published studies.
May 12, 2026
GLP-1 vs Retatrutide for Fat Loss: Which Wins?
GLP-1 agonists vs retatrutide for fat loss: head-to-head on efficacy, safety, and practical use. Evidence-based verdict for informed decision-making.
May 12, 2026
MOTS-c: What It Is and What the Evidence Shows
A research-focused primer on MOTS-c: its mitochondrial origin, metabolic mechanisms, preclinical findings, human trial data, and honest assessment of what is and isn't established.
May 12, 2026
TB-500 for Tendon Recovery: What the Evidence Shows
A deep-dive into TB-500's evidence base for tendon recovery — covering preclinical data, proposed mechanisms, published dosing protocols, and where it stands vs. alternatives.
